Deals & Cases


On January 7, 2020, NewAlpha Asset Management and Capital Croissance announced that BIOBank, a French human origin bone bank, acquired Neutromedics AG, a Swiss distributor of orthobiologics and orthopedic implants. BIOBank, a portfolio company of the growth equity fund NewAlpha Verto and of a fund managed by Capital Croissance, accelerates its international development with this first external growth transaction.

The Homburger team advising BIOBank in this transaction was led by partner Daniel Hasler (Corporate | M&A) and included associate Margrit Marti (Corporate | M&A), partner Franz Hoffet and associate Yves Bianchi (both Competition | Regulatory), counsel Peter Müller (Tax), associates Aliénor de Dardel (Employment and Executive Compensation) and Andrea Ziswiler (Banking and Finance) as well as junior associate Gregor Schifferle (Corporate | M&A).